Pascal Longchamp

Dr. Pascal Longchamp has been the Chief Business Officer of Evolva SA since March 2005. Dr. Longchamp has spent over 14 years in the Biotechnology & Pharmaceutical industry, covering R&D, Management and Business Development positions on the West Coast (US) and in Switzerland. Previously he was the Director of Business Development at Phyllom (2003), where he developed its Vaccines and Agricultural franchises, and a part of Maxygen's successful IPO in December 1999. At Maxygen, Dr. Longchamp was in charge of two corporate alliances and promotion of its gene shuffling platform technology to third parties. At Phistem, Maxygen and Phyllom, Dr. Longchamp was responsible for corporate development, strategic alliances, in and out-licensing, leading international research collaboration and US government contract with the Department of Defense. He received a Ph.D. in Genetics and Microbiology from the University of Lausanne, followed by post-doctoral researches at UC Berkeley in Molecular Biology and at Lawrence Berkeley National Laboratory in Biodefense. Dr. Longchamp has an MBA from HEC Business School, Lausanne. Dr. Longchamp is a founder and Chairman of the Board of Phistem (2009).